DE69318546D1 - Verfahren zur herstellung von prostaglandin e - Google Patents
Verfahren zur herstellung von prostaglandin eInfo
- Publication number
- DE69318546D1 DE69318546D1 DE69318546T DE69318546T DE69318546D1 DE 69318546 D1 DE69318546 D1 DE 69318546D1 DE 69318546 T DE69318546 T DE 69318546T DE 69318546 T DE69318546 T DE 69318546T DE 69318546 D1 DE69318546 D1 DE 69318546D1
- Authority
- DE
- Germany
- Prior art keywords
- prostaglandin
- group
- represents hydrogen
- participating
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- -1 allyl ester Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 abstract 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 abstract 1
- 235000019253 formic acid Nutrition 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0235—Nitrogen containing compounds
- B01J31/0237—Amines
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/0234—Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
- B01J31/0255—Phosphorus containing compounds
- B01J31/0267—Phosphines or phosphonium compounds, i.e. phosphorus bonded to at least one carbon atom, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, the other atoms bonded to phosphorus being either carbon or hydrogen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/04—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing carboxylic acids or their salts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/2208—Oxygen, e.g. acetylacetonates
- B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
- B01J31/223—At least two oxygen atoms present in one at least bidentate or bridging ligand
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2291—Olefins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026492 | 1992-02-05 | ||
| JP2015192 | 1992-02-05 | ||
| PCT/JP1993/000115 WO1993016041A1 (en) | 1992-02-05 | 1993-02-02 | Process for producing prostaglandin e |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69318546D1 true DE69318546D1 (de) | 1998-06-18 |
| DE69318546T2 DE69318546T2 (de) | 1998-09-10 |
Family
ID=26357058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69318546T Expired - Lifetime DE69318546T2 (de) | 1992-02-05 | 1993-02-02 | Verfahren zur herstellung von prostaglandin e |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5648526A (de) |
| EP (1) | EP0627416B1 (de) |
| JP (1) | JP3153241B2 (de) |
| KR (1) | KR100255355B1 (de) |
| AT (1) | ATE166048T1 (de) |
| AU (1) | AU665980B2 (de) |
| CA (1) | CA2129537C (de) |
| DE (1) | DE69318546T2 (de) |
| WO (1) | WO1993016041A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2099822T3 (es) * | 1991-04-22 | 1997-06-01 | Taisho Pharmaceutical Co Ltd | Analogo de prostaglandina e1. |
| JP3316018B2 (ja) | 1992-03-13 | 2002-08-19 | 大正製薬株式会社 | Ｅ型プロスタグランジン類またはそのエステルの製造方法 |
| AU770343B2 (en) * | 1999-09-06 | 2004-02-19 | Fumie Sato | Prostaglandin E analogues |
| EP2143712A1 (de) * | 2008-07-10 | 2010-01-13 | Sandoz AG | Verbessertes Verfahren zur Herstellung von Prostaglandinen und Prostaglandin-Analogen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5221392A (en) * | 1975-08-13 | 1977-02-17 | Teijin Ltd | Process for preparing prostaglandin derivatives |
| JPS5874661A (ja) * | 1981-10-30 | 1983-05-06 | Teijin Ltd | Ｅ型プロスタン酸誘導体の新規製造法 |
| ES2099822T3 (es) * | 1991-04-22 | 1997-06-01 | Taisho Pharmaceutical Co Ltd | Analogo de prostaglandina e1. |
-
1993
- 1993-02-02 DE DE69318546T patent/DE69318546T2/de not_active Expired - Lifetime
- 1993-02-02 US US08/256,924 patent/US5648526A/en not_active Expired - Lifetime
- 1993-02-02 EP EP93902553A patent/EP0627416B1/de not_active Expired - Lifetime
- 1993-02-02 JP JP51394093A patent/JP3153241B2/ja not_active Expired - Lifetime
- 1993-02-02 KR KR1019940702557A patent/KR100255355B1/ko not_active IP Right Cessation
- 1993-02-02 WO PCT/JP1993/000115 patent/WO1993016041A1/ja active IP Right Grant
- 1993-02-02 AU AU33680/93A patent/AU665980B2/en not_active Ceased
- 1993-02-02 CA CA002129537A patent/CA2129537C/en not_active Expired - Fee Related
- 1993-02-02 AT AT93902553T patent/ATE166048T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0627416A1 (de) | 1994-12-07 |
| JP3153241B2 (ja) | 2001-04-03 |
| CA2129537A1 (en) | 1993-08-06 |
| EP0627416B1 (de) | 1998-05-13 |
| AU665980B2 (en) | 1996-01-25 |
| KR950700246A (ko) | 1995-01-16 |
| WO1993016041A1 (en) | 1993-08-19 |
| EP0627416A4 (de) | 1995-05-03 |
| ATE166048T1 (de) | 1998-05-15 |
| US5648526A (en) | 1997-07-15 |
| DE69318546T2 (de) | 1998-09-10 |
| CA2129537C (en) | 2002-05-07 |
| KR100255355B1 (ko) | 2000-05-01 |
| AU3368093A (en) | 1993-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE149509T1 (de) | Verfahren zur herstellung von 2-chlor-2'- desoxyadenosin | |
| ATE422200T1 (de) | Verfahren zur herstellung substituierter nikotinsäureester | |
| ATE320412T1 (de) | Verfahren zur herstellung von hydroxyphenylcarbonsäureestern | |
| DE69318546D1 (de) | Verfahren zur herstellung von prostaglandin e | |
| ATE123276T1 (de) | Verfahren zur herstellung von 5,6- dihydroxyindolinen. | |
| ATE36318T1 (de) | Verfahren zur herstellung von azetidinderivaten und zwischenprodukte. | |
| ATE384067T1 (de) | Verfahren zur herstellung von 3-cephemderivaten | |
| ATE169929T1 (de) | Verfahren zur herstellung von schwefelsäurehalbestern | |
| ATE61329T1 (de) | Verfahren zur herstellung von rooperol, hypoxosid und deren derivaten. | |
| ATE155132T1 (de) | Verfahren zur herstellung von amino- thiadiazolylacetylhaliden | |
| DE69619402D1 (de) | Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten | |
| ATE25680T1 (de) | Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten. | |
| ATE118762T1 (de) | Verfahren zur herstellung von 4- methylsulfonylbenzoesäurederivate und zwischenprodukte. | |
| ATE135693T1 (de) | Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung | |
| ATE236109T1 (de) | Verfahren zur herstellung von 1,5-pentandiol- derivaten | |
| DE69030884D1 (de) | Verfahren zur herstellung von norbornan-sulfonamidderivat | |
| ATE167474T1 (de) | Verfahren zur herstellung von n-alkylpyrazolen | |
| KR850001742A (ko) | 큐말산 에스테르의 제조방법 | |
| HK1114084A1 (en) | Method for producing thiocarbamate derivative | |
| FI915109A (fi) | Foerfarande foer framstaellning av alifatisk amid och salter daerav. | |
| ATE967T1 (de) | Verfahren zur herstellung von xanthonderivaten. | |
| DE68906654D1 (de) | Verfahren zur herstellung von konjugierten dienen. | |
| ATE116288T1 (de) | Verfahren zur herstellung von sulfonylisocyanaten. | |
| SE7900889L (sv) | Sett att framstella xantonderivat | |
| DE3778765D1 (de) | Verfahren zur herstellung von antibiotika. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |